Our results demonstrate, for the first time, that evaluating the expression of the profibrotic factors PDGFA and TGFB could be key to developing complementary tools that would help overcome the difficulty of diagnosing CTD-ILD. This evidence concerns the gene TGFB1 and interstitial lung disease.